Publications

Journal Article Epublish 5 citations
Electronic publication date
April 25, 2024

View on Pubmed.gov 38660388 | View on doi.org 10.3389/fnmol.2...

Extracellular vesicles mediate inflammasome signaling in the brain and heart of Alzheimer's disease mice.

Search for publications in this journal Front Mol Neurosci

Abstract

Introduction

Alzheimer's disease (AD) is an inflammatory neurodegenerative disease characterized by memory loss and cognitive impairment that worsens over time. AD is associated with many comorbidities, including cardiovascular disease that are associated with poorer outcomes. Comorbidities, especially heart disease and stroke, play a significant role in the demise of AD patients. Thus, it is important to understand how comorbidities are linked to AD. We have previously shown that extracellular vesicle (EV)-mediated inflammasome signaling plays an important role in the pathogenesis of brain injury and acute lung injury after traumatic brain injury.

Methods

We analyzed the cortical, hippocampal, ventricular, and atrial protein lysates from APP/PS1 mice and their respective controls for inflammasome signaling activation. Additionally, we analyzed serum-derived EV for size, concentration, and content of inflammasome proteins as well as the EV marker CD63. Finally, we performed conditioned media experiments of EV from AD patients and healthy age-matched controls delivered to cardiovascular cells in culture to assess EV-induced inflammation.

Results

We show a significant increase in Pyrin, NLRP1, caspase-1, and ASC in the brain cortex whereas caspase-8, ASC, and IL-1β were significantly elevated in the heart ventricles of AD mice when compared to controls. We did not find significant differences in the size or concentration of EV between groups, but there was a significant increase of caspase-1 and IL-1β in EV from AD mice compared to controls. In addition, conditioned media experiments of serum-derived EV from AD patients and age-matched controls delivered to cardiovascular cells in culture resulted in inflammasome activation, and significant increases in TNF-α and IL-2.

Conclusion

These results indicate that EV-mediated inflammasome signaling in the heart may play a role in the development of cardiovascular diseases in AD patients.

References

Neurochem Int. 2019 Jul;127:29-37

Mol Neurodegener. 2016 Mar 03;11:23

J Clin Med. 2020 Oct 12;9(10):

Transl Res. 2023 Apr;254:1-12

Cited by 5 citations (total)

Journal Article Review Research Support, Non-U.S. Gov't

Dog Aging: A Comprehensive Review of Molecular, Cellular, and Physiological Processes.

Electronic publication date January 8, 2025

Search for publications in this journal Cells

Gabriella Guelfi [...] Margherita Maranesi et al.

The aging process is a multifactorial biological phenomenon starting at birth and persisting throughout life, characterized by a decline in...

Journal Article Review

Small Extracellular Vesicles in Neurodegenerative Disease: Emerging Roles in Pathogenesis, Biomarker Discovery, and Therapy.

Electronic publication date August 14, 2025

Search for publications in this journal Int J Mol Sci

Mousumi Ghosh [...] Damien D Pearse et al.

Neurodegenerative diseases (NDDs) such as Alzheimer's, Parkinson's, ALS, and Huntington's pose a growing global challenge due to their complex pathobiology...

Conflict of interest statement

JR, WD, and RK are co-founders and managing members of InflamaCORE, LLC and have licensed patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes. JR, WD, and RK are Scientific Advisory Board Members of ZyVersa Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

MeSH

Specialties

Copyright

Copyright © 2024 Cyr, Cabrera Ranaldi, Hadad, Dietrich, Keane and de Rivero Vaccari.